Sinopharm Group (01099) said its net profit attributable to equity holders for the nine months ended 30 September 2016 rose 26.8% year-on-year to Rmb3,596 million.
Basic and diluted earnings per share were Rmb1.3.
Total operating revenue amounted to Rmb191,839.85 million, an increase of 12.97% from a year earlier.
28/10/2016 16:44
Sinopharm (01099) 9-month net profit up 26.8% to Rmb3.6bn
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
